Migalastat Capsules (RLD Galafold) had estimated annual sales of USD 388 million in the U.S. (IQVIA MAT December 2023).
It is noteworthy that fraudulent copycats of both Zepbound and Mounjaro are increasing in the market amid this shortage.
More than 250 million people live with chronic hepatitis B infection, leading to increasing deaths each year.
It is the generic equivalent of Novartis’ Kisqali tablets.
During the study, the researchers collated and analysed data from the National Family Health Survey (NFHS) conducted in 2015–2016 and…
While many prominent players faced setbacks, including layoffs and product shelving, we remained steadfast, Chadha told Financial Express.com.
The injectable plant can produce 285 millions Vials/Ampoules annually and the Granulated products plant will produce 13,200 tonne annually, Aurobindo…
According to the list, some of the major companies whose samples have been flagged include Glenmark Pharmaceuticals, Micro Labs, Sun…
This increase in prices comes after medicine prices were hiked by 12 per cent last year and 10 per cent…
The WHO also maintains that suicide is an important cause of death among pregnant and postpartum women. Although psychosis is…
Scrutinise your overall lifestyle to know what isn’t working for you or where you’re going wrong, and things that may…
NPPA order irks industry coping with high input costs.
Kobayashi Pharmaceutical had been selling benikoji products for years, with a million packages sold over the past three fiscal years,…
Meanwhile, Gerresheimer is already producing products for GLP-1 drugs in Germany and is ramping up a plant in Mexico that…
During this study, the researchers analysed anonymized hospital records for more than 110,000 people aged over 65 in New South…
Additionally, when lidocaine is applied over large areas of skin, particularly on irritated or broken skin, for prolonged periods of…
Eslicarbazepine Acetate Tablets (RLD Aptiom) had estimated annual sales of USD 354 million in the U.S. (IQVIA MAT January 2024).
Abbott’s Leptos (sibutramine hydrochloride) is currently the only approved medication for obesity in India